Welcome to the HTL blog!

Polynucleotides (PN) play an increasingly important role in regenerative medicine and are now assessed against criteria such as biological quality, safety, traceability, and responsible sourcing. In this context, the origin of polynucleotides has become a structuring factor, influencing both the final product profile and the confidence of stakeholders across the medical value chain. Among the various available sources, polynucleotides derived from wild salmon stand out for a set of specific characteristics. 

Microneedles today represent a highly promising advancement in transdermal medicine and tissue drug delivery. At the interface between biomaterials, biotechnology, and pharmacology, they enable targeted and minimally invasive delivery of active compounds directly into the dermis and epidermis.

Recent studies demonstrate their potential in regenerative aesthetics, wound healing, immunology and oncology, particularly in the treatment of melanoma.

Osteoarthritis is a degenerative joint disorder, often leading to chronic pain and reduced mobility as cartilage deteriorates over time.

Due to its viscoelastic properties, Hyaluronic acid (HA), a naturally occurring molecule in the body and a major component of the extracellular matrix, is an ideal candidate for addressing these degenerative processes of joint diseases. Recognized for its lubricating properties, HA is also shaping the management of osteoarthritis and rheumatologic diseases through its multi-faceted therapeutic potential.

Since 1992, HTL Biotechnology has pioneered hyaluronic acid (HA) production through bacterial fermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology, and rheumatology. 

HTL Biotechnology’s industrial platform is the backbone of its leadership in pharmaceutical-grade biopolymers. Built on more than 30 years of expertise, it combines not only reliability, and the highest quality standards, but also sustainability.

In the realm of modern medicine, few biopolymers have demonstrated as much clinical versatility as hyaluronic acid (HA).

Hyaluronic Acid (HA) has already secured its place as a gold-standard biopolymer across medical and aesthetic fields. Celebrated for its unique viscoelasticity, hydration capacity, and biocompatibility, HA has long been used in ophthalmic surgery, joint viscosupplementation, wound healing, and dermal fillers. But today, HA is undergoing a radical transformation. It’s becoming an active, programmable platform—a cornerstone of the next generation of drug delivery and regenerative medicine.

Earlier this year, during the IMCAS World Congress, we interviewed three experts in the field of aesthetic medicine and are thrilled to share these exclusive interviews !